✦ LIBER ✦

Minority variants associated with resistance to HIV-1 nonnucleoside reverse transcriptase inhibitors during primary infection

✍ Scribed by F. Nicot; A. Saliou; S. Raymond; K. Sauné; M. Dubois; P. Massip; B. Marchou; P. Delobel; J. Izopet

Book ID: 119292700
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 324 KB
Volume: 55
Category: Article
ISSN: 1386-6532
DOI: 10.1016/j.jcv.2012.06.018

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Differential Impact of Resistance-Associ

Differential Impact of Resistance-Associated Mutations to Protease Inhibitors and Nonnucleoside Reverse Transcriptase Inhibitors on HIV-1 Replication Capacity

✍ Hsieh, Szu-Min; Pan, Sung-Ching; Chang, Sui-Yuan; Hung, Chien-Ching; Sheng, Wang 📂 Article 📅 2013 🏛 Mary Ann Liebert 🌐 English ⚖ 394 KB

Treatment of primary HIV-1 infection wit

Treatment of primary HIV-1 infection with nonnucleoside reverse transcriptase inhibitor-based therapy is effective and well tolerated

✍ S Portsmouth; N Imami; A Pires; J Stebbing; J Hand; M Nelson; F Gotch; BG Gazzar 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB

Short Communication : Lamivudine Resista

Short Communication : Lamivudine Resistance of HIV Type 1 Does Not Delay Development of Resistance to Nonnucleoside HIV Type 1-Specific Reverse Transcriptase Inhibitors as Compared with Wild-Type HIV Type 1

✍ JONCKHEERE, HEIDI; WITVROUW, MYRIAM; DE CLERCQ, ERIK; ANNÉ, JOZEF 📂 Article 📅 1998 🏛 Mary Ann Liebert 🌐 English ⚖ 632 KB

Emergence and genetic evolution of HIV-1

Emergence and genetic evolution of HIV-1 variants with mutations conferring resistance to multiple reverse transcriptase and protease inhibitors

✍ Cabana, Marta; Clotet, Bonaventura; Mart�nez, Miguel-Angel 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 302 KB

The emergence of genotypic resistance in protease and reverse transcriptase (RT) gene regions was longitudinally evaluated in plasma samples from a group of 12 HIV-1-infected patients treated with different combination of antiretroviral therapies and selected on the basis of their clinical failure.

94 Combination therapy with AZT prevents

94 Combination therapy with AZT prevents selection of HIV-1 variants that are highly resistant to the nonnucleoside reverse transcriptase inhibitor L-697, 661: E.A. Emini, S. Staszewski, C.L. Schneider, J.A. Waterbury, W.A. Schleif, R. Goehler, A. Deussen, S. Duerr, F.E. Massari, G.B. Calandra, B. Hoffstedt, and V.W. Byrnes; Merck Research Laboratories, West Point, PA, USA; Klinikum der Johann Wolfgang Goethe-Universitat, Frankfurt, Germany

📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 92 KB